Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs PolyPid Ltd. (PYPD)

Foghorn Therapeutics Inc. and PolyPid Ltd. are both Biotechnology companies. Foghorn Therapeutics Inc. and PolyPid Ltd. are of similar size ($115.2M and $113.1M). PolyPid Ltd. has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, PolyPid Ltd. leads on 7 and Foghorn Therapeutics Inc. on 3.

Valuation

Metric FHTX PYPD Biotechnology median
P/E n/m n/m 10.60
P/S 3.60 n/m 9.40
P/B n/m 25.59 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.22 n/m 0.66
EV/Sales (0.42) n/m 9.02
Earnings yield (52.41%) (24.30%) (32.88%)
Free cash flow yield (63.84%) (55.78%) (23.13%)

Profitability

Metric FHTX PYPD Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% (243.59%) (51.96%)
Return on assets (30.06%) (119.05%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FHTX PYPD Biotechnology median
Revenue growth (TTM) 51.98% — 6.76%
EPS growth (last fiscal year) 25.32% 57.43% 29.88%
Revenue growth, 5-year CAGR 135.14% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX PYPD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 1.35 4.97
Net debt to EBITDA 1.88 0.39 1.01

Dividend

Metric FHTX PYPD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FHTX PYPD Biotechnology median
Market cap 113.13m 115.16m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack